EA Pharma acquires oligotherapy firm Labcatal

17 February 2020 - Deborah Wilkes

Premium

Equilibre Attitude (EA Pharma) is strengthening its presence in oligotherapy by acquiring fellow French company Labcatal for an undisclosed sum.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: